<?xml version="1.0" encoding="UTF-8"?>
<p>In contrast, 2-ethyl-6-methyl-3-hydroxypyridine succinate (mexidol, emoxipine) has noticeable iron chelating activity (Andrusishina 
 <italic>et al</italic>. 
 <xref rid="bib9" ref-type="bibr">2014</xref>), antioxidative activity (Voronina 
 <xref rid="bib290" ref-type="bibr">2001</xref>) and the ability to inhibit serine proteases and matrix metalloproteases (Akhmedov, Budylgin and Dolgikh 
 <xref rid="bib5" ref-type="bibr">2010</xref>). Mexidol has many such biological effects and has been proposed for the effective use as a supportive agent in the treatment of pneumonia (Ilyashenko 
 <italic>et al</italic>. 
 <xref rid="bib115" ref-type="bibr">2001</xref>; Luzhnikov 
 <italic>et al</italic>. 
 <xref rid="bib165" ref-type="bibr">2006</xref>) and viral infections (Pavelkina, Yerovichenkov and Pak 
 <xref rid="bib210" ref-type="bibr">2010</xref>).
</p>
